CDRH Director Discusses Uncertainty Guidance

Citeline Podcasts - Podcast tekijän mukaan Citeline

Kategoriat:

CDRH Director Jeff Shuren spoke to Medtech Insight at the MDIC Annual Forum about a risk-benefit uncertainty guidance US FDA released that day. He says he hopes the guidance will provide clarity to industry about the circumstances when FDA will accept different levels of uncertainty.

Visit the podcast's native language site